Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

High levels of fat in your liver increase your risk of serious health problems, such as diabetes, high blood pressure and ...

编者按脂肪性肝病简称脂肪肝，是一组以病理学显著肝细胞脂肪变性或影像学弥漫性脂肪肝为特征的异质性疾病。脂肪肝根据病理上肝细胞脂肪变性、炎症损伤及纤维化程度，可分为单纯性脂肪肝、脂肪性肝炎以及肝纤维化和肝硬化，根据病因可分为酒精性肝病（ALD）、代谢相关 ...

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with ...

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

Fatty liver disease is a common condition that can lead to severe liver damage. Dr Eric Berg DC has shared a 'detox' smoothie he recommends daily to remove fat.

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

In 2020, life expectancy for people with cystic fibrosis was just 36. A new drug available on the NHS may be about to change ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flowThe ...